Literature DB >> 20555080

Melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

R Dummer1, A Hauschild, M Guggenheim, L Jost, G Pentheroudakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20555080     DOI： 10.1093/annonc/mdq188

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  23 in total

1.  Asymptomatic melanoma of the superior cavo-atrial junction: The challenge of imaging.

Authors:  Tobias Krüger; Martin Heuschmid; Ralf Kurth; Ulrich A Stock; Stephen M Wildhirt
Journal:  World J Cardiol       Date:  2012-01-26

Review 2.  Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma.

Authors:  Pascale Dequen; Paul Lorigan; Jeroen P Jansen; Marc van Baardewijk; Mario J N M Ouwens; Srividya Kotapati
Journal:  Oncologist       Date:  2012-09-28

3.  [Plantar ulcer in a multimorbid patient].

Authors:  V Bekou; I Baltisser; R Dummer; J Traber
Journal:  Chirurg       Date:  2013-03       Impact factor: 0.955

4.  Evaluation of multiple serum markers in advanced melanoma.

Authors:  Angel Díaz-Lagares; Estíbaliz Alegre; Ainhoa Arroyo; María González-Cao; Maria E Zudaire; Santiago Viteri; Salvador Martín-Algarra; Alvaro González
Journal:  Tumour Biol       Date:  2011-08-20

5.  Melanoma in primary care. The role of the general practitioner.

Authors:  D Buckley; C McMonagle
Journal:  Ir J Med Sci       Date:  2013-10-04       Impact factor: 1.568

6.  Good clinical and radiological response to BRAF inhibitor in patient with metastatic thin melanoma.

Authors:  Keith Ian Quintyne; Shirley Baker; Fintan Wallis; Rajnish Gupta
Journal:  BMJ Case Rep       Date:  2012-06-28

Review 7.  A Global Review of Melanoma Follow-up Guidelines.

Authors:  Shannon C Trotter; Novie Sroa; Richard R Winkelmann; Thomas Olencki; Mark Bechtel
Journal:  J Clin Aesthet Dermatol       Date:  2013-09

8.  Expression of MAGE-C1/CT7 and MAGE-C2/CT10 predicts lymph node metastasis in melanoma patients.

Authors:  Alessandra Curioni-Fontecedro; Natko Nuber; Daniela Mihic-Probst; Burkhardt Seifert; Davide Soldini; Reinhard Dummer; Alexander Knuth; Maries van den Broek; Holger Moch
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

9.  Proteomics in melanoma biomarker discovery: great potential, many obstacles.

Authors:  Michael S Sabel; Yashu Liu; David M Lubman
Journal:  Int J Proteomics       Date:  2011-10-11

10.  Malignant melanoma.

Authors:  Aída Ortega Candil; Cristina Rodríguez Rey; José Luis Carreras Delgado
Journal:  ISRN Dermatol       Date:  2012-12-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.